(MENAFN) Merck & Co Inc., the world's third-biggest drugmaker, announced that it plans to buyback USD5 billion of its common stock, reported AP.
Between January and April, the company bought back around 17.8 million shares, worth USD772 million.
It is worth noting that the buyback move is part of a program announced earlier by the New Jersey-based company to repurchase USD15 billion worth of its shares.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.